[Sponsored] This article is part of a series on eliminating blind spots in the patient journey by leveraging real-world data. The post Using RWD, SDoH and Patient Mapping to Eliminate Blind Spots from the Patient Journey appeared first on MedCity News.
That is the clever title of recent American Economic Review publication by Cyrus Aghamolla, Pinar Karaca-Mandic, Xuelin Li, Richard T. Thakor. The abstract is below. This study examines the link between credit supply and hospital health outcomes. We use bank stress tests as exogenous shocks to credit access for hospitals that have lending relationships with…
This brief analyzes Medicaid enrollment and spending trends for FY 2024 and FY 2025, based on data provided by state Medicaid directors as part of the 24th annual survey of Medicaid directors.
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” Someone in America dies by suicide every 11 minutes. It’s that common. But not normal. Humans have evolved over centuries to survive. So when people try to kill themselves, something…
Regeneron Pharmaceuticals’ Otarmeni is now approved for treating hearing loss from an ultra-rare genetic mutation found in an estimated 50 newborns per year. While Regeneron will offer this gene therapy for free, the approval came with a rare pediatric disease priority review voucher that the company can sell for hundreds of millions of dollars. The…
While CREST-2 can stand as a guideline for understanding ACS therapies in case-by-case scenarios, it’s critical that trial conclusions do not replace clinical judgment and years of previous research. The post Why CREST-2 Trial Results Should Inform, Not Replace, Clinical Judgment appeared first on MedCity News.
A new WTW survey reveals that over half of employers exceeded their healthcare budgets in 2024 and expect rising costs to continue, prompting a shift toward cost-containment strategies, vendor accountability, AI adoption and alternative plan designs. The post WTW: Half of Employers Exceeded Their Healthcare Budgets in 2024 appeared first on MedCity News.
Despite achieving statistically signficant improvement in progression-free survival in North American and European patients, Summit’s drug ivonescimab fell short of the other Phase 3 goal measuring overall survival. It’s the first Phase 3 readout for an emerging class of bispecific antibodies that treat cancer by blocking two targets, PD-1 and VEGF. The post Summit Lung…
Elli Lilly has been in the news lately because of the announced $1 billion investment in a joint innovation lab with Nvidia, an AI powerhouse player. But AI drug discovery is only part of the story of where AI can be leveraged in biopharma. The post Lilly’s Chief Information & Digital Officer: AI Use Goes…
Yusuf Qasim, president of payments optimization at Zelis, talks about how his company’s platform is seeking to rebuild the healthcare payment process. The platform aims to eliminate unnecessary manual work for both payers and providers. Watch or listen now! The post MedCity Pivot Podcast: How the Right Payment Tech Can Foster Better Payer-Provider Relationships appeared…